Title of article :
COVID-19 and literature evidence: should we publish anything and everything?
Author/Authors :
Chan, Jeremy Department of Cardiothoracic Surgery - University Hospitals Coventry and Warwickshire, Coventry, UK , Oo, Shwe Department of Cardiothoracic Surgery - Bristol Royal Infirmary, Bristol, UK , Ting Chor, Cheryl Yan St. George’s Medical School - University of London, London, UK , Yim, Daniel St. George’s Medical School - University of London, London, UK , Shi Kai Chan, Jeffrey Department of Medicine and Therapeutics - Division of Cardiology - Prince of Wales Hospital, Shatin, New Territories, Hong Kong , Harky, Amer Department of Cardiothoracic Surgery - Liverpool Heart and Chest Hospital, Liverpool, UK
Pages :
6
From page :
1
To page :
6
Abstract :
COVID-19 first presented in Wuhan, Hubei Province, China in December 2019. Since then, it has rapidly spread across the world, and is now formally considered a pandemic. As of 4th of May more than 3.2 million people have been infected and over 250,000 people have died. Since the very start, scientists and researchers have tried to utilize this case to publish academic experiences and suggestions toward fighting this virus, which is lethal in some cases. To date, more than 9,000 academic papers have been published since December 2019. The quality of publications varies from a plane letter to the editor to randomized studies. This review aims to analyse the current published literature related to COVID-19 and assess the quality of such articles. (www.actabiomedica.it)
Keywords :
COVID-19 , review , bibliometric analysis
Journal title :
Acta bio-medica : Atenei Parmensis
Serial Year :
2020
Full Text URL :
Record number :
2618720
Link To Document :
بازگشت